|
19
|
Bertuol & Valentini (2006) BRA |
35♀ 33♂ |
12-16 |
A, V |
< 1.0 |
CE |
CS |
SCAT |
SG/AT/CO |
50% |
|
20
|
Carré et al. (2006) CAN |
14♂ |
18.2 (1.48) |
HK |
NI |
CE |
CS |
CSAI-2 |
CO |
61% |
|
21
|
Fernandes & Nunes (2006) BRA |
9♂ |
27.8 (NI) |
FT |
> 5.0 |
CE |
CS |
STAI-S |
CO |
59% |
|
22
|
Han et al. (2006) KOR |
277♂ |
17.3 (2.99) |
A, BB, CR, D, G, R, RG, J, JV, S, SW, TW, SW, WT |
NI |
NI |
CS |
STAI-ST |
AT/CO |
55% |
|
23
|
Stavrou et al. (2006) GRC |
52♀ 47♂ |
20.0 (4.5) |
A, CC, ST, SW |
> 7.9 (4.6) |
CE |
CS |
CSAI-2D |
CO |
61% |
|
24
*
|
Gonçalves & Belo (2007) BRA |
47♀ 58♂ |
15.2 (1.76) |
F, H, SW, SSW, V |
NI |
LP |
CS |
SCAT |
SG/AT/CO |
61% |
|
25
|
Haneishi et al. (2007) USA |
18♀ |
18-24 |
S |
NI |
CE/LP |
CS |
SAS |
AT |
55% |
|
26
*
|
Vasconcelos-Raposo et al. (2007) BRA |
529♂ |
23.0 (4.23) |
S |
11.21 (4.47) |
LP |
CS |
CSAI-2 |
SG/AT/CO |
55% |
|
27
*
|
Abrahamsen et al. (2008) NOR |
89♀ 101♂ |
17.8 (5.7) |
A, BD, G, O, SW, T |
NI |
CE |
CS |
SAS |
SG |
61% |
|
28
*
|
García et al. (2008) ESP |
48♀ 49♂ |
14.7 (1.3) |
J |
NI |
CE |
CS |
CSAI-2 |
SG |
57% |
|
29
*
|
Géczi et al. (2008) HUN |
52♂ |
U-18: 16.78 (NI) A-18: 27.21 (NI) |
IHK |
NI |
LP |
CS |
CSAI-2 |
SG |
50% |
|
30
*
|
Hanton et al. (2008) UK |
97♀ 120♂ |
20.4 (2.92) |
A, C, RG, T |
NI |
NI |
CS |
SAS-M CSAI-2M |
AT |
61% |
|
31
|
Kaplan et al. (2008) TUR |
22♂ |
22.6 (2.0) |
S |
10.8 (1.9) |
CE |
PL |
STAI-S |
CO |
48% |
|
32
|
Ramiro et al. (2008) ESP |
18♀ |
24.0 (3.9) |
HK |
NI |
CE |
CS |
STAI-S |
AT |
52% |
|
33
|
Abenza et al. (2009) ESP |
10♂ |
NI |
B |
NI |
CE |
CS |
STAI-ST |
CO |
52% |
|
34
*
|
Filaire et al. (2009) FRA |
8♀ 8♂ |
♀: 20.2 (1.0) ♂: 22.2 (2.8) |
T |
10.5 (3.2) |
CE |
CS |
CSAI-2D |
SG |
55% |
|
35
*
|
Géczi et al. (2009) HUN |
95♂ |
16-20 |
IHK |
NI |
CE |
CS |
CSAI-2 |
SG |
57% |
|
36
*
|
Grossbard et al. (2009) USA |
498♀ 540♂ |
11.5 (1.5) |
BB, HK, S, V |
NI |
CE |
CS |
SAS-2 |
SG |
64% |
|
37
|
Guillén & Sánchez (2009) ESP |
84♀ |
FD: 23.2 (4.0) NT: 24.9 (3.4) |
B |
> 5.3 (4.9) |
CE |
CS |
STAI-ST |
SG/CO |
50% |
|
38
|
Kim et al. (2009) KOR |
12♂ |
EL: 16.2 (1.38) NEL: 15.8 (0.75) |
G |
NI |
CE |
CS |
CSAI-2 |
AT |
52% |
|
39
|
Draper et al. (2010) NZL |
9♂ |
20.3 (1.1) |
CB |
2.75 (1.75) |
AS |
E |
CSAI-2R |
CO |
42% |
|
40
|
Fernandes & Silva (2010) BRA |
110♂ 151♂ |
JJ: 23.0 (5.06) SF: 18.1 (5.08) |
JJ, SF |
> 4.02 (4.08) |
CE |
CS |
CSAI-2 |
SG/AT |
57% |
|
41
|
Ferreira et al. (2010) BRA |
12♀ |
21.5 (2.9) |
V |
≥ 8.0 |
CE |
CS |
SCAT |
SG/CO |
34% |
|
42
|
Interdonato et al. (2010) BRA |
73♂ |
13.2 (1.88) |
B, J, S, SW, V |
3.43 (1.79) |
LP |
CS |
SCAT |
SG/AT/CO |
57% |
|
43
*
|
Nicholls et al. (2010) UK |
55♀ 252♂ |
21.3 (2.8) |
VS |
> 9.1 (5.2) |
CE |
CS |
CSAI-2R |
SG/AT/CO |
52% |
|
44
|
Aguirre-Loaiza & Bermúdez (2011) COL |
93♂ |
17.4 (2.0) |
S |
7.7 (1.9) |
CE |
CS |
STAI-S |
SG/AT/CO |
70% |
|
45
*
|
Kolayis & Sari (2011) TUR |
44♀ 82♂ |
20.5 (2.93) |
J |
8.86 (3.84) |
CE |
CS |
CSAI-2 STAI-S |
SG/AT |
50% |
|
46
*
|
León-Prados & García (2011) ESP |
8♀ 8♂ |
♀: 10.6 (1.19) ♂: 20.6 (2.92) |
AG |
> 2.0 |
CE |
CS |
CSAI-2RD |
SG/AT/CO |
61% |
|
47
*
|
Modroño & Guillén (2011) ESP |
19♀ 60♂ |
24.7 (5.8) |
W |
NI |
CE |
CS |
CSAI-2 SCAT |
SG/AT |
57% |
|
48
|
Parry et al. (2011) AUT |
3♀ 9♂ |
42.5 (3.6) |
TH |
> 5.0 |
CE |
CS |
CSAI-2 |
CO |
50% |
|
49
|
Radochonski et al. (2011) POL |
132♀♂ |
20.5 (4.5) |
A, K |
NI |
NI |
CS |
CSAI-2 |
CO |
52% |
|
50
*
|
Vieira et al. (2011)BRA |
28♀ 47♂ |
14-19 |
A |
♀: 3.95 (2.45) ♂: 3.39 (2.12) |
CE |
CS |
CSAI-2 |
SG |
57% |
|
51
*
|
Borrego et al. (2012) PRT |
44♀ 322♂ |
17.1 (1.6) |
S |
NI |
CE |
CS |
CSAI-2 |
SG |
57% |
|
52
|
Singley et al. (2012) USA |
8♀ 14♂ |
18-40 |
SD |
NI |
LP |
CS |
CSAI-2M |
CO |
64% |
|
53
*
|
Souza et al. (2012) BRA |
18♀ 33♂ |
17.8 (2.85) |
SW |
> 4.11 (4.25) |
CE |
CS |
CSAI-2 SCAT |
SG/AT |
64% |
|
54
|
Villas Boas et al. (2012) BRA |
48♂ |
12-13 |
F |
NI |
CE |
CS |
CSAI-2 |
AT/CO |
45% |
|
55
|
Asghar et al. (2013) |
793♂ |
12-18 |
HK, S |
NI |
LP |
CS |
CSAI-2 |
SG |
61% |
|
56
*
|
Fernandes et al. (2013) BRA |
70♀ 233♂ |
24.2 (5.07) |
B, F, H, J, JJ, K, R, S, SF, SW, T, V |
9.03 (5.92) |
NI |
CS |
CSAI-2R |
SG/AT/CO |
66% |
|
57
*
|
Ibarzábal (2013) ESP |
40♀ 52♂ |
29.1 (5.61) |
BB |
11.02 (4.79) |
CE |
CS |
CSAI-2 |
SG |
57% |
|
58
|
Jeong & Park (2013) KOR |
9♀ 57♂ |
KR: 43.2 (NI) NKR: 33.5 (NI) |
T |
> 8.0 |
CE |
CS |
CSAI-2 |
SG |
66% |
|
59
*
|
Morales et al. (2013) ESP |
14♀ 10♂ |
NT: 22.3 (2.11) IT: 24.1 (1.78) |
J |
NI |
CE |
CS |
CSAI-2R |
AT/CO |
57% |
|
60
|
Parnabas & Mohamood (2013) MYS |
147♀♂ |
NI |
S |
NI |
CE |
CS |
CSAI-2 |
SG |
57% |
|
61
|
Ramis et al. (2013) ESP |
422♀♀ 363♂ |
12.7 (2.20) |
AG, B, H, SW, SSW, T, WP |
NI |
CE |
CS |
SAS-2 |
CO |
55% |
|
62
*
|
Ruiz-Juan & Zarauz (2013) ESP |
71♀ 330♂ |
♀: 45.7 (10.25) ♂: 47.9 (9.14) |
A |
NI |
CE |
CS |
CSAI-2R |
SG/AT/CO |
52% |
|
63
|
Arruda et al. (2014) BRA |
24♂ |
17.8 (0.4) |
B |
NI |
CE |
CS |
CSAI-2 |
CO |
66% |
|
64
*
|
Fernandes et al. (2014) BRA |
71♀ 196♂ |
24.3 (5.62) |
B, H, F, FV, J, JJ, K, MC, R, S, SF, SW, V |
10.03 (5.62) |
CE |
CS |
CSAI-2R |
AT |
66% |
|
65
*
|
González & Fayos (2014) ESP |
22♀ 90♂ |
27.4 (4.9) |
SW, T, V |
NI |
LP |
CS |
STAI-ST |
SG/AT/CO |
68% |
|
66
|
Han et al. (2014) KOR |
33♀♂ |
NI |
BS |
NI |
CE |
CS |
CSAI-2 STAI-T |
AT |
57% |
|
67
|
Silva et al. (2014) BRA |
13♀ |
16.3 (1.1) |
V |
4.7 (NI) |
CE |
PL |
CSAI-2 BAI SSA |
CO |
59% |
|
68
*
|
Stenling et al. (2014) AUS |
163♀ 152♂ |
♀: 19.4 (3.0) ♂: 20.6 (4.0) |
FB, IHK |
♀: > 10.1 ♂: > 12.1 |
CE |
CS |
CSAI-2R |
SG |
73% |
|
69
|
Wolf et al. (2014) CAN |
108♀ 144♂ |
20.32 (1.85) |
B, IHK, V |
> 10.03 (4.22) |
CE |
CS |
CSAI-2D |
SG/AT/CO |
61% |
|
70
|
Cunniffe et al. (2015) UK |
24♂ |
26.2 (0.9) |
RG |
NI |
CE |
PL |
CSAI-2R |
AT/CO |
55% |
|
71
|
Fernandez-Fernandez et al. (2015) ESP |
12♀ |
13.0 (0.3) |
T |
6.0 (2.8) |
CE |
PL |
CSAI-2R |
AT/CO |
52% |
|
72
|
Pesce et al. (2015) ITA |
25♂ |
28.6 (5.34) |
KB |
NI |
CE |
PL |
STAI-S |
CO |
59% |
|
73
*
|
Machado et al. (2016) BRA |
24♀ 23♂ |
16.1 (0.34) |
V |
4.9 (1.99) |
CE |
CS |
CSAI-2 |
SG/AT |
84% |
|
74
*
|
Kurimay et al. (2017) USA |
20♀ 80♂ |
10-60 |
TT |
NI |
CE |
CS |
CSAI-2R |
SG |
75% |
|
75
*
|
Hagan et al. (2017) |
E: 21♀ 26♂ SE: 14♀ 29♂ |
26.7 (5.29) |
T |
9.6 (5.12) |
CE |
CS |
CSAI-2D |
SG |
89% |
|
76
*
|
Nikseresht et al. (2017) |
14♂ |
11.7 (0.82) |
SW |
NI |
CE |
CS |
SCAT |
SG |
77% |
|
77
|
Arruda et al. (2017) |
12♂ |
18.6 (0.50) |
B |
NI |
CE |
CS |
CSAI-2 |
CO |
77% |